Acasti Pharma Inc. (ACST): Volume dana dhuwit perusahaan

Logo korporat perusahaan acastipharma.com (ACST)

Acasti Pharma cash asset dynamics are driven by the outsourcing of production and clinical operations to third-party contractors, as well as a licensing approach to the distribution of cardiology developments. The value 0.02 is recorded as the baseline liquidity value. Current capital relies on the search for strategic partners to commercialize treatments for rare pathologies and the successful completion of trials for ataxia drugs.

ACST - Volume dana dhuwit perusahaan Acasti Pharma ing rentang 04.07.2022 - 28.10.2024

Rincian analitis lan laporan data perusahaan Acasti Pharma Inc. (ACST)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:Acasti Pharma
Produk mawa merek acastipharma.com

The margin of safety for Acasti Pharma (ACST) is determined by the volume of liquid assets, which eliminates the need for secondary offerings. A stable reputation as a developer of rare therapies allows the company to attract capital based on trust. Analyzing this cash liquidity chart, an investor can see the actual resources available to fund R&D without incurring a debt load. This metric measures the business's ability to autonomously sustain its operating activities, characterizing the asset as a defensive instrument with moderate risk.